Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NNMT | P40261 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 4/20 | 0.43 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.42 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.35 |
| ▸ | TTR | P02766 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 2/20 | 0.34 |
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.34 |
| ▸ | BRAF | P15056 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.33 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.33 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21282111 | 0.90 | SMN1; SMN2 (0.46) | NNMTUSP2CES1APOBEC3AAPOBEC3G | |
| SCHEMBL24141267 | 0.89 | CES1 (0.40) | NNMTUSP2CES1APOBEC3AAPOBEC3G | |
| SCHEMBL25715295 | 0.87 | NNMT (0.35) | NNMTUSP2CES1APOBEC3AAPOBEC3G | |
| SCHEMBL21282117 | 0.86 | ALDH1A1 (0.37) | NNMTUSP2CES1APOBEC3AAPOBEC3G | |
| SCHEMBL21282102 | 0.85 | CES1 (0.46) | USP2CES1APOBEC3AAPOBEC3GP2RX4 | |
| SCHEMBL21282133 | 0.83 | CES1 (0.44) | USP2CES1P2RX4ACHECTRB1 | |
| SCHEMBL25712850 | 0.81 | NNMT (0.31) | NNMTUSP2CES1 | |
| SCHEMBL21282131 | 0.81 | P2RX4 (0.51) | USP2CES1P2RX4BCHEACHE | |
| SCHEMBL25712152 | 0.79 | KCNN4 (0.48) | USP2CES1P2RX4BCHESMN1; SMN2 | |
| SCHEMBL21282089 | 0.78 | CES1 (0.40) | USP2CES1APOBEC3AAPOBEC3GSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230193038-A1 | METHODS OF DIGITAL PRINTING USING MODIFIED INDIGO COMPOUNDS | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2023-06-22 | — | — | US | disclosed |
| US-20230193038-A1 | METHODS OF DIGITAL PRINTING USING MODIFIED INDIGO COMPOUNDS | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2023-06-22 | — | — | US | disclosed |
| US-20210403718-A1 | Modified Indigo Compounds and Methods of Dyeing a Substrate Using a Modified Indigo Compound | THE H.D. LEE COMPANY, INC. (US) | 2021-12-30 | — | — | US | disclosed |
| US-11208559-B2 | Modified indigo compounds and methods of dyeing a substrate using a modified indigo compound | THE H.D. LEE COMPANY, INC. (US) | 2021-12-28 | — | — | US | disclosed |
| US-20210189643-A1 | FOAM DYEING METHODS USING MODIFIED INDIGO COMPOUNDS | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2021-06-24 | — | — | US | disclosed |
| US-20190256710-A1 | MODIFIED INDIGO COMPOUNDS AND METHODS OF DYEING A SUBSTRATE USING A MODIFIED INDIGO COMPOUND | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2019-08-22 | — | — | US | disclosed |
| US-7670390-B2 | Use of latent pigments for high-remanence dyeing, composition containing the said pigments and processes using them | L'OREAL S.A. (FR) | 2010-03-02 | — | — | US | disclosed |
| US-20080172806-A1 | USE OF LATENT PIGMENTS FOR HIGH-REMANENCE DYEING, COMPOSITION CONTAINING THE SAID PIGMENTS AND PROCESSES USING THEM | L'OREAL | 2008-07-24 | — | — | US | disclosed |
| US-7326255-B2 | Use of latent pigments for high-remanence dyeing, composition containing the said pigments and processes using them | L'OREAL S.A. (FR) | 2008-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080172806-A1 | USE OF LATENT PIGMENTS FOR HIGH-REMANENCE DYEING, COMPOSITION CONTAINING THE SAID PIGMENTS AND PROCESSES USING THEM | KRT18, LMNA, CRYZ | NNMT 2682/4885USP2 2405/4885CES1 1184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.